Clinical Trial Update: Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

This document reports the status of a Phase 1 study of AMG 509 in participants with metastatic castration-resistant prostate cancer, which is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• AMG 509

Snippet

Sponsor: Amgen | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING